Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 95

Sort by

Sort Order Select

Journal Articles

The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma

Dai Chihara, Graça M. Dores, Christopher R. Flowers, Lindsay M. Morton

Blood (2021) 138 (9): 785–789.

https://doi.org/10.1182/blood.2020010497

Published: 2021

Includes: Supplemental data

Journal Articles

Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study

Kerry A. Rogers, MD, Michael A. Boxer, MD, Michael Y. Choi, MD, Richy Agajanian, MD, Donald M. Arnold, MD, Catherine M. Broome, MD, Joshua J. Field, MD, Irina Murakhovskaya, MD, Donna Chow, Robert P. Numerof, PhD, Hanzhe Zheng, PhD, Sandy Tong, MD, David J. Kuter

Blood (2019) 134 (Supplement_1): 3518.

https://doi.org/10.1182/blood-2019-126509

Published: 2019

Journal Articles

Clinical Activity of CC-90009, a Cereblon E3 Ligase Modulator and First-in-Class GSPT1 Degrader, As a Single Agent in Patients with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML): First Results from a Phase I Dose-Finding Study

Blood (2019) 134 (Supplement_1): 232.

https://doi.org/10.1182/blood-2019-123966

Published: 2019

Journal Articles

Hispanic Race Is Associated with Increased Risk of Severe Sepsis in 1913 Hospitalizations of Children with AML and Infection

Beth Savage, MSN, ANP, Peter D Cole, MD, Charlotte Thomas-Hawkins, PhD RN, Jerod Stapleton, PhD, Pamela de Cordova, PhD RN-BC, Linda Flynn, PhD RN, FAAN

Blood (2019) 134 (Supplement_1): 1327.

https://doi.org/10.1182/blood-2019-123534

Published: 2019

Journal Articles

Detection of Dysregulated Host Response By Flow Cytometry May Pre-Empt Early Diagnosis of Sepsis after Cardiac Surgery

Ullas Mony, PhD, Sanju S, M.Tech, Paresh Jain, MD, Sugavanan K, M.Sc, Agnes Sebastian, B.Tech, Theertha M, B.Sc, Neeraj Sidharthan, MDDM, Praveen K Varma, MS MCh

Blood (2019) 134 (Supplement_1): 4863.

https://doi.org/10.1182/blood-2019-129782

Published: 2019

Journal Articles

Signaling mechanisms inducing hyporesponsiveness of phagocytes during systemic inflammation

Nicole Freise, Alina Burghard, Theresa Ortkras, Niklas Daber, Achmet Imam Chasan, Saskia-L. Jauch, Olesja Fehler, Julia Hillebrand, Mosab Schakaki, Jessica Rojas, Bodo Grimbacher, Thomas Vogl, Andreas Hoffmeier, Sven Martens, Johannes Roth, Judith Austermann

Blood (2019) 134 (2): 134–146.

https://doi.org/10.1182/blood.2019000320

Published: 2019

Includes: Supplemental data

Journal Articles

Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation

K. Scott Baker, Wendy M. Leisenring, Pamela J. Goodman, Ralph P. Ermoian, Mary E. Flowers, G. Schoch, Rainer Storb, Brenda M. Sandmaier, H. Joachim Deeg

Blood (2019) 133 (26): 2790–2799.

https://doi.org/10.1182/blood.2018874115

Published: 2019

Includes: Supplemental data

Journal Articles

Risk of Second Primary Malignancies in Chronic Lymphocytic Leukemia

Anuhya Kommalapati, MD, Sri Harsha Tella, MD, Gaurav Goyal, MBBS

Blood (2018) 132 (Supplement 1): 3581.

https://doi.org/10.1182/blood-2018-99-120123

Published: 2018

Journal Articles

Hyperactivation of Plasmin Following Severe Burn Is Associated with Systemic Inflammation and Coagulopathy

Breanne HY Gibson, BSc, Patrick R Keller, BA, BM, Stephanie N Moore-Lotridge, BSc, J. Blair Summitt, MD, Jonathan G Schoenecker, MD PhD

Blood (2018) 132 (Supplement 1): 3780.

https://doi.org/10.1182/blood-2018-99-116904

Published: 2018

Journal Articles

Severe Sepsis As Immune Stimulation and Protection from Relapse of Childhood Acute Lymphoblastic Leukemia (ALL): Results from a Pilot Study and Validation of Events in a National Administrative Dataset

Alix E. Seif, MD, Viviane C. Cahen, Yimei Li, PhD, Caitlin Walfoort Elgarten, MD, Amanda M. Dinofia, MD, Jennifer J. Wilkes, MD, Lena Winestone, MD, Yuan-Shung V. Huang, MS, Julie C Fitzgerald, MD, Brian T Fisher, DO, Gregor S. D. Reid, PhD, Kelly D Getz, Richard Aplenc, MD

Blood (2017) 130 (Supplement 1): 3445.

https://doi.org/10.1182/blood.V130.Suppl_1.3445.3445

Published: 2017

Journal Articles

Plasma Inflammatory Protein Profiles Distinguish Hemophagocytic Lymphohistiocytosis from Sepsis and SIRS

Harshal Abhyankar, MS, Carl E. Allen, MD PhD, Howard Lin, Baruch Goldberg, Brooks Scull, Kenneth L. McClain, MD PhD, Jordana Goldman, Trung Nguyen, Michael B. Jordan, MD, Tsz-kwong Man, Olive S. Eckstein, MD, Joseph Lubega, Dalia Bashir, Rikhia Chakraborty, PhD BSc, MSc, Hector Wong, Eyal Muscal, Daniel Zinn, MD

Blood (2017) 130 (Supplement 1): 1011.

https://doi.org/10.1182/blood.V130.Suppl_1.1011.1011

Published: 2017

Journal Articles

Incidence of Secondary Malignancies in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Era of Tyrosine Kinase Inhibitors (TKI)

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Susan M. O'Brien, MD, Farhad Ravandi, MBBS, Marina Konopleva, MD PhD, Gautam Borthakur, MD, Guillermo Garcia-Manero, MD, William G Wierda, MD PhD, Naval Daver, MD, Alessandra Ferrajoli, MD, Koichi Takahashi, MD, Preetesh Jain, MBBS,MDDM,PhD, Mary B. Rios, RN, Sherry Pierce, BSN, BA, Elias J. Jabbour, MD, Jorge E. Cortes, MD

Blood (2017) 130 (Supplement 1): 1609.

https://doi.org/10.1182/blood.V130.Suppl_1.1609.1609

Published: 2017

Journal Articles

Pretransplant Clinical Factors Can be Used to Predict the Risk of Cytokine Release Syndrome after Haploidentical Peripheral Blood Transplantation

Ramzi Abboud, MD BS, Kathryn Trinkaus, PhD, John F DiPersio, MD PhD, Camille N. Abboud, MD, Rizwan Romee, MD

Blood (2017) 130 (Supplement 1): 1967.

https://doi.org/10.1182/blood.V130.Suppl_1.1967.1967

Published: 2017

Journal Articles

Population Trends in Incidence of Second Malignant Neoplasm and Cause-Specific Mortality in Patients with Multiple Myeloma

Luciano J. Costa, MD PhD, Kelly N. Godby, MD, Saurabh Chhabra, MD, Robert Frank Cornell, MD, Parameswaran Hari, MD MRCP, MS, Smita Bhatia, MDMPH

Blood (2017) 130 (Supplement 1): 682.

https://doi.org/10.1182/blood.V130.Suppl_1.682.682

Published: 2017

Journal Articles

Secondary Cancers in Hodgkin Lymphoma: A Comprehensive Analysis of Incidence and Trends in Survivors

Vivek Kumar, Mohit Garg, Abhinav Chandra, Valerie S. Mayorga, Sikander Ailawadhi

Blood (2017) 130 (Supplement 1): 913.

https://doi.org/10.1182/blood.V130.Suppl_1.913.913

Published: 2017

Journal Articles

A Rare Case of Hemophagocytic Lymphohistiocytosis of Unknown Etiology

Ida Micaily, MD, Marie-Helene Gagnon, MD, Richard Friedenheim, MD, Jason A. Damsker, MD

Blood (2017) 130 (Supplement 1): 4831.

https://doi.org/10.1182/blood.V130.Suppl_1.4831.4831

Published: 2017

Journal Articles

Changes in Second Primary Malignancies (SPM) after Hodgkin Lymphoma over Time in the United States

Amy Steele, BS, Qian Li, MS, Ann M Brunson, MS, Aaron S. Rosenberg, MD, Ted Wun, MD FACP, FRCPA, Theresa H.M. Keegan, PhD MS

Blood (2017) 130 (Supplement 1): 4097.

https://doi.org/10.1182/blood.V130.Suppl_1.4097.4097

Published: 2017

Journal Articles

No Excess Risk of Second Malignancies in Chronic Myeloid Leukemia (CML) Patients Treated with Tyrosine Kinase Inhibitors (TKIs)

Lilian Iglesias, Sudipto Mukherjee, MD PhD MPH, Aziz Nazha, MD, Anjali S. Advani, MD, Aaron T. Gerds, MDMS, Hetty E. Carraway, MD MBA, Matt Kalaycio, MD, Jaroslaw P. Maciejewski, PhD MD FACP, Navneet S. Majhail, MD MS, Mikkael A. Sekeres, MD MS

Blood (2017) 130 (Supplement 1): 2872.

https://doi.org/10.1182/blood.V130.Suppl_1.2872.2872

Published: 2017

Journal Articles

National Early Warning Score (NEWS) and Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Validation in AML Patient during Febrile Neutropenia

Barbara Nicolino, MD, Umberto Vitolo, MD, Ernesta Audisio, Stefano D'Ardia, Chiara Frairia, MD, Giorgia Iovino, MD, Andrea Evangelista, MSc, Giovannino Ciccone, Semra Aydin

Blood (2017) 130 (Supplement 1): 5016.

https://doi.org/10.1182/blood.V130.Suppl_1.5016.5016

Published: 2017

Journal Articles

A Phase I Study of the Anti-CD79b THIOMAB TM -Drug Conjugate DCDS0780A in Patients (pts) with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Alex F. Herrera, MD, Manish R Patel, MD, John M. Burke, MD, Ranjana H. Advani, MD, Bruce D. Cheson, MD, Jeffrey P. Sharman, MD, Elicia Penuel, Andrew G. Polson, PhD, Ning Leng, PhD, Chunze Li, PhD, Eva Schuth, PhD, Anjali Vaze, PhD, Divya Samineni, PhD, Rebecca Elstrom, MDMA, Catherine S Diefenbach

Blood (2017) 130 (Supplement 1): 4129.

https://doi.org/10.1182/blood.V130.Suppl_1.4129.4129

Published: 2017

NARROW

The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma

Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study

Clinical Activity of CC-90009, a Cereblon E3 Ligase Modulator and First-in-Class GSPT1 Degrader, As a Single Agent in Patients with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML): First Results from a Phase I Dose-Finding Study

Hispanic Race Is Associated with Increased Risk of Severe Sepsis in 1913 Hospitalizations of Children with AML and Infection

Detection of Dysregulated Host Response By Flow Cytometry May Pre-Empt Early Diagnosis of Sepsis after Cardiac Surgery

Signaling mechanisms inducing hyporesponsiveness of phagocytes during systemic inflammation

Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation

Risk of Second Primary Malignancies in Chronic Lymphocytic Leukemia

Hyperactivation of Plasmin Following Severe Burn Is Associated with Systemic Inflammation and Coagulopathy

Severe Sepsis As Immune Stimulation and Protection from Relapse of Childhood Acute Lymphoblastic Leukemia (ALL): Results from a Pilot Study and Validation of Events in a National Administrative Dataset

Plasma Inflammatory Protein Profiles Distinguish Hemophagocytic Lymphohistiocytosis from Sepsis and SIRS

Incidence of Secondary Malignancies in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) in the Era of Tyrosine Kinase Inhibitors (TKI)

Pretransplant Clinical Factors Can be Used to Predict the Risk of Cytokine Release Syndrome after Haploidentical Peripheral Blood Transplantation

Population Trends in Incidence of Second Malignant Neoplasm and Cause-Specific Mortality in Patients with Multiple Myeloma

Secondary Cancers in Hodgkin Lymphoma: A Comprehensive Analysis of Incidence and Trends in Survivors

A Rare Case of Hemophagocytic Lymphohistiocytosis of Unknown Etiology

Changes in Second Primary Malignancies (SPM) after Hodgkin Lymphoma over Time in the United States

No Excess Risk of Second Malignancies in Chronic Myeloid Leukemia (CML) Patients Treated with Tyrosine Kinase Inhibitors (TKIs)

National Early Warning Score (NEWS) and Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Validation in AML Patient during Febrile Neutropenia

A Phase I Study of the Anti-CD79b THIOMAB TM -Drug Conjugate DCDS0780A in Patients (pts) with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only